Literature DB >> 1080677

Treatment of life-threatening hemorrhage due to acquired factor VIII inhibitor.

T Pintado, H F Taswell, E J Bowie.   

Abstract

An otherwise healthy elderly man developed massive, life-threatening, sublingual bleeding associated with an idiopathic factor VIII inhibitor. The patient was treated wtih cyclophosphamide, steroids, factor VIII concentrates, and repeated plasmapheresis (including three times with NCI-IBM blood-cell separator). Rapid clinical and laboratory improvement occurred, with complete disappearance of the inhibitor. The patient has remained well, without evidence of an inhibitor, for 8 mo. The possible role of each of the therapeutic measures in the disappearance of the inhibitor and the possible pathogenetic mechanism of this disorder are discussed. A high mortality rate and a striking incidence of sublingual hematoma have been observed in cases in the literature.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1080677

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  5 in total

Review 1.  Potential for plasma exchange in children.

Authors:  E A Robinson
Journal:  Arch Dis Child       Date:  1982-04       Impact factor: 3.791

2.  Failure of factor VIII inhibitor bypassing activity (Feiba) to secure haemostasis in haemophilic patients with antibodies.

Authors:  D H Parry; A L Bloom
Journal:  J Clin Pathol       Date:  1978-11       Impact factor: 3.411

3.  Plasma exchange and human factor VIII concentrate in managing haemophilia A with factor VIII inhibitors.

Authors:  R T Wensley; R F Stevens; A M Burn; I W Delamore
Journal:  Br Med J       Date:  1980-11-22

4.  Successful Long Term Eradication of Factor VIII Inhibitor in Patients with Acquired Haemophilia A in Saudi Arabia.

Authors:  Galila Zaher; Soheir Adam
Journal:  Mediterr J Hematol Infect Dis       Date:  2012-04-02       Impact factor: 2.576

Review 5.  Surgery-associated acquired hemophilia A: a report of 2 cases and review of literature.

Authors:  Umar Zeb Khan; Xiangwu Yang; Matiullah Masroor; Abdul Aziz; Hui Yi; Hai Liu
Journal:  BMC Surg       Date:  2020-09-23       Impact factor: 2.102

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.